NASDAQ: QNTM
Quantum Biopharma Ltd Stock Ownership - Who owns Quantum Biopharma?

Insider buying vs selling

Have Quantum Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when QNTM insiders and whales buy or sell their stock.

QNTM Shareholders

What type of owners hold Quantum Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Advisorshares Investments LLC1.30%49,633$111.18kInstitution
Citadel Advisors LLC0.42%15,863$35.53kInstitution
Marex Group PLC0.35%13,436$30.10kInstitution
Gts Securities LLC0.32%12,300$27.55kInstitution
Jane Street Group LLC0.29%10,892$24.40kInstitution
Virtu Financial LLC0.27%10,406$23.31kInstitution
Osaic Holdings Inc0.14%5,270$11.80kInstitution
Steward Partners Investment Advisory LLC0.11%4,381$9.81kInstitution
Ubs Group Ag0.04%1,710$3.83kInstitution
Tucker Asset Management LLC0.03%1,114$2.50kInstitution

1 of 3

QNTM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNTM3.36%0.00%
GELS0.80%13.96%
YCBD1.92%98.08%Net Selling
BFRI20.07%27.76%
SBFM2.34%81.62%

Quantum Biopharma Stock Ownership FAQ

Who owns Quantum Biopharma?

Quantum Biopharma (NASDAQ: QNTM) is owned by 3.36% institutional shareholders, 0.00% Quantum Biopharma insiders, and 96.64% retail investors. Advisorshares Investments LLC is the largest individual Quantum Biopharma shareholder, owning 49,633.00 shares representing 1.30% of the company. Advisorshares Investments LLC's Quantum Biopharma shares are currently valued at $111.18k.

If you're new to stock investing, here's how to buy Quantum Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.